Multiple sclerosis: Epstein-Barr virus is present in the brain of most cases examined
Multiple sclerosis ( MS ) is a chronic neuroinflammatory condition of the central nervous system ( CNS ). It is a major cause of neurological disability in young adults, particularly women.
What triggers the destruction of myelin sheaths covering nerve fibres is unknown.
Both genetic and infectious agents have been implicated. Of the infectious agents, Epstein-Barr virus ( EBV ), a common herpesvirus, has the strongest epidemiological and serological evidence. However, the presence of EBV in the CNS and demonstration of the underlying mechanism(s) linking EBV to the pathogenesis of multiple sclerosis remain to be elucidated.
Researchers aimed at understanding the contribution of EBV infection in the pathology of multiple sclerosis.
They examined 1055 specimens ( 440 DNA samples and 615 brain tissues ) from 101 MS and 21 non-MS cases for the presence of EBV using PCR and EBER-in situ hybridization ( EBER-ISH ).
EBV was detected by PCR and/or EBER-ISH in 91/101 ( 90% ) of MS cases compared to only 5/21 ( 24% ) of non-MS cases with other neuropathologies.
None of the samples were PCR positive for other common herpesviruses ( HSV-1, CMV, HHV-6 ).
By quantitative PCR, EBV viral load in MS brain was mainly low to moderate in most cases.
However, in 18/101 ( 18% ) of MS cases, widespread but scattered presence of EBV infected cells was noted in the affected tissues by EBER-ISH.
Immunohistochemical analysis of EBV gene expression in the 18 heavily infected cases, revealed that the EBV latent protein EBNA1, and to a lesser extent the early lytic protein BZLF1 were expressed.
Furthermore, using double-staining researchers have shown for the first time that astrocytes and microglia, in addition to B-cells can also be infected.
This is the most comprehensive study demonstrating that EBV is present and transcriptionally active in the brain of most cases of multiple sclerosis and supports a role for the virus in MS pathogenesis.
Further studies are required to address the mechanism of EBV involvement in MS pathology. ( Xagena )
Hassani A et al, PLoS ONE 13(2): e0192109
Helicase-primase inhibitors for HSV-2 infection: Pritelivir has reduced the rates of genital HSV shedding
Pritelivir, a viral helicase-primase complex inhibitor, exhibits antiviral activity in vitro and in animal models of herpes simplex virus (...
Corneal diseases: gene transfer of integration defective anti-HSV-1 meganuclease to human corneas ex vivo
Corneal graft rejection is a major problem in chronic herpetic keratitis (HK ) patients with latent infection. A new...
An experimental vaccine intended to prevent genital herpes disease in women, although generally safe and well-tolerated, proved ineffective when tested...
Oral antiviral prophylaxis should be considered for patients with frequent recurrences of corneal disease
Taking oral antiviral medications following infection with the herpes simplex virus may be associated with a reduced risk of recurring...
Human papillomavirus ( HPV ) was found to be the main risk factor associated with increased incidence of an unusual...
Oral sex may be a risk factor for nongonococcal urethritis ( NGU ), one of the most common sexually transmitted...
Researchers at the University of Michigan discovered a receptor that appears to function as one "lock" that herpes simplex virus...
Preliminary results of a phase I study showed that a single injection of a genetically engineered virus has shown...